National News
NAFDAC halts Artemether/Lumefantrine registration

The National Agency for Food and Drug Administration and Control (NAFDAC) has halted the registration of Multi-Dose Anti-Malarial (Artemether/Lumefantrine) dry powder for oral suspension.
The announcement was made in a public alert No. 01/2025, released on the agency’s website yesterday.
NAFDAC explained that the decision was made due to the instability of the reconstituted formulations, which could lead to a loss of efficacy over time.
According NAFDAC, the suspension applies to all locally manufactured and imported Multi-Dose Artemether/Lumefantrine dry powder for oral use.
“NAFDAC will no longer accept new applications, renewals, or variations for this product.”
According to the Agency, stability studies revealed that reconstituted Artemether/Lumefantrine oral suspension becomes unstable after mixing, leading to a loss
Ifeoma Nwovu
-
FCT News2 days ago
Major gridlock on Gwagwalada-Giri-Zuba Expressway, motorists trapped
-
Sports1 day ago
NBBF Announces Dates for 2025 Zenith Bank Women’s Basketball League Finals
-
FCT News2 days ago
FCT Resident Doctors begin Seven-Day warning strike over poor conditions
-
News1 day ago
Senate blocks Natasha Akpoti-Uduaghan’s planned resumption, cites pending Appeal
-
News2 days ago
JAMB panel uncovers tech-driven malpractice undermining admissions
-
News1 day ago
Fuel supply disrupted nationwide as NUPENG strike grounds Depot operations
-
News2 days ago
Troops kill notorious bandit leader Kachalla Bala, five others in Kogi
-
News18 hours ago
FG rolls out Green Project with 11,000 Palm Trees in Awka